Author

Rupinder K Kanwar

All India Institute of Medical Sciences (AIIMS), Bhopal, M.P. India - Cited by 5,931 - Translational Medicine - Oncology - Nanomedicine - Tissue engineering and Regenerative Medicine - Cardiology

Biography

Dr. Rupinder K Kanwar  is an Associate professor in the department of Translational Medicine All India Institute of Medical Sciences (AIIMS), Bhopal, M.P. India. His study interests major on Translational Medicine. Currently , Dr. Rupinder K Kanwar  is the author/editors/reviewer in several international journals. He published 5 articles in many journals and the articles are informative and got good citations.
Title
Cited by
Year
Progress on Azadirachta indica Based Biopesticides in Replacing Synthetic Toxic Pesticides
S Chaudhary, RK Kanwar, A Sehgal, DM Cahill, CJ Barrow, R Sehgal, ...Frontiers in plant science 8, 610, 2017201
288
2017
Doxorubicin conjugated to immunomodulatory anticancer lactoferrin displays improved cytotoxicity overcoming prostate cancer chemo resistance and inhibits tumour development in …
JS Shankaranarayanan, JR Kanwar, AJA Al-Juhaishi, RK KanwarScientific reports 6 (1), 1-16, 2016201
55
2016
Engineered atherosclerosis-specific zinc ferrite nanocomplex-based MRI contrast agents
R Chaudhary, K Roy, RK Kanwar, K Walder, JR KanwarJournal of nanobiotechnology 14 (1), 1-17, 2016201
32
2016
Chasing the personalized medicine dream through biomarker validation in colorectal cancer
H Patil, SG Saxena, CJ Barrow, JR Kanwar, A Kapat, RK KanwarDrug Discovery Today 22 (1), 111-119, 2017201
31
2017
Aged macular degeneration: current therapeutics for management and promising new drug candidates
AJ Abd, RK Kanwar, JR KanwarDrug Discovery Today 22 (11), 1671-1679, 2017201
25
2017
Biodegradable Eri silk nanoparticles as a delivery vehicle for bovine lactoferrin against MDA-MB-231 and MCF-7 breast cancer cells
K Roy, YS Patel, RK Kanwar, R Rajkhowa, X Wang, JR KanwarInternational journal of nanomedicine, 25-44, 2016201
24
2016
Integrated 3D printed scaffolds and electrical stimulation for enhancing primary human cardiomyocyte cultures
SD Adams, A Ashok, RK Kanwar, JR Kanwar, AZ KouzaniBioprinting 6, 18-24, 202
17
2017
Evidence of tumour microenvironment and stromal cellular components in retinoblastoma
R Raguraman, S Parameswaran, JR Kanwar, V Khetan, P Rishi, ...Ocular Oncology and Pathology 5 (2), 85-93, 2019201
16
2019
Iron imbalance in cancer: Intersection of deficiency and overload
T Basak, RK KanwarCancer Medicine 11 (20), 3837-3853, 2022202
12
2022
Utility of nanomedicine targeting scar-forming myofibroblasts to attenuate corneal scarring and haze
AM Ibrahim Al-Mashahedah, RK Kanwar, JR KanwarNanomedicine 14 (8), 1049-1072, 2019201
12
2019
Pharmacogenomics and personalized medicine in type 2 diabetes mellitus: potential implications for clinical practice
P Venkatachalapathy, S Padhilahouse, M Sellappan, T Subramanian, ...Pharmacogenomics and Personalized Medicine, 1441-1455, 2021202
9
2021
E-Cadherin Aptamer-Conjugated delivery of Doxorubicin for targeted inhibition of prostate cancer cells
R Chaudhary, K Roy, RK Kanwar, RN Veedu, S Krishnakumar, ...Australian Journal of Chemistry 69 (10), 110-1116, 2016201
8
2016
Nanotheranostic based iron oxide (Fe3O4) saturated lactoferrin nanocapsules for colonic adenocarcinoma
SK Kamalapuram, RK Kanwar, JR KanwarJournal of Biomedical Nanotechnology 12 (9), 175-1773, 2016201
8
2016
Neocarzinostatin, aptamer conjugates for targeting EpCAM-positive tumor cells
PK Athyala, JR Kanwar, S Chitipothu, RK Kanwar, S Krishnakumar, ...Anticancer research 3 (), 3615-3629, 20120
7
2017
SurR9C84A protects and recovers human cardiomyocytes from hypoxia induced apoptosis
A Ashok, JR Kanwar, UM Krishnan, RK KanwarExperimental Cell Research 350 (1), 19-31, 20120
7
2017
Iron bond bovine lactoferrin for the treatment of cancers and anemia associated with cancer cachexia
A Aboda, W Taha, I Attia, A Gad, MM Mostafa, MA Abdelwadod, ...Advances and Avenues in the Development of Novel Carriers for Bioactives and …, 2020202
7
2020
A study of gene expression of survivin, its antiapoptotic variants, and targeting survivin in vitro for therapy in retinoblastoma
J Samuel, RK Kanwar, JR Kanwar, V Khetan, S KrishnakumarJournal of Pediatric Hematology/Oncology 38 (), e230-e242, 2016201
7
2016
Multimodal nanomedicine strategies for targeting cancer cells as well as cancer stem cell signalling mechanisms
JR Kanwar, RM Samarasinghe, SK Kamalapuram, RK KanwarMini Reviews in Medicinal Chemistry 17 (18), 188-195, 2017201
6
2017
Nanoparticles Advancing Cancer Immunotherapy
MMH Chowdhury, K Kubra, RK Kanwar, JR KanwarBiomedical Applications of Graphene and 2D Nanomaterials, 283-304, 2019201
5
2019
Targeted theranostics against solid cancer using metal bond milk protein and aptamers
S Chaudhary, R Kaur Kanwar, J Rakesh KanwarCurrent Topics in Medicinal Chemistry 17 (18), 2100-2111, 2017201
3
2017

Referred From: https://scholar.google.com.au/citations?user=btUYKH8AAAAJ&hl=en

Cited by
Citations 5931
h-index 43
i10-index 108
Recommended Journals
Open Access Journals